Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Bülent Sargin(Katholisches Klinikum Lünen/Werne , St.-Marien-Hospital Lünen), Hubert Serve(Goethe University Frankfurt)
Cited by 209
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
|Molecular Cell|2009|315
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185